Description
The abstract explicitly states that mechanisms by which amyloid assemblies trigger neurodegeneration remain largely unknown. Understanding these mechanisms is critical for developing targeted therapeutic interventions for Parkinson’s disease and related synucleinopathies.
Gap type: open_question Source paper: Preparation of α-Synuclein Amyloid Assemblies for Toxicity Experiments. (2018, Methods in molecular biology (Clifton, N.J.), PMID:29886526)